Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
049960
vs
K
KOSPI 200
Over the past 12 months, Cell Biotech Co Ltd has underperformed KOSPI 200, delivering a return of +27% compared to KOSPI 200's +54% growth.
Stocks Performance
049960 vs KOSPI 200
Performance Gap
049960 vs KOSPI 200
Performance By Year
049960 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cell Biotech Co Ltd
Glance View
Cell Biotech Co Ltd makes probiotic products and related health supplements. The company develops, manufactures, and sells lactic acid bacteria-based ingredients and finished products that are used for digestive health and general wellness. It serves both consumers and other companies, including partners that need probiotic ingredients or private-label products. Its business is built around selling finished probiotic supplements and supplying probiotic strains and formulations to food, health, and pharmaceutical customers. In simple terms, Cell Biotech earns money by selling products under its own brands and by manufacturing or supplying probiotics for other companies that put them into capsules, powders, drinks, or other health products. What makes the company’s role distinct is that it sits between microbiology research and consumer health products. It does not just resell vitamins or supplements; it works with live bacterial cultures, production know-how, and product formulation to turn those cultures into shelf-stable goods that can be sold through retail and business-to-business channels.